Canavan disease

Studies on the knockout mouse

Reuben Matalon, Kimberlee Michals-Matalon, Sankar Surendran, Stephen K. Tyring

Research output: Chapter in Book/Report/Conference proceedingConference contribution

6 Citations (Scopus)

Abstract

Canavan disease (CD) is an autosomal recessive disorder, characterized by spongy degeneration of the brain. Patients with CD have aspartoacylase (ASPA) deficiency, which results accumulation of N-acetylaspartic acid (NAA) in the brain and elevated excretion of urinary NAA. Clinically, patients with CD have macrocephaly, mental retardation and hypotonia. A knockout mouse for CD which was engineered, also has ASPA deficiency and elevated NAA. Molecular studies of the mouse brain showed abnormal expression of multiple genes in addition to ASPA deficiency. Adenoassociated virus mediated gene transfer and stem cell therapy in the knockout mouse are the latest attempts to alter pathophysiology in the CD mouse.

Original languageEnglish (US)
Title of host publicationAdvances in Experimental Medicine and Biology
PublisherSpringer New York
Pages77-93
Number of pages17
Volume576
ISBN (Print)9780387301716
DOIs
StatePublished - 2006

Publication series

NameAdvances in Experimental Medicine and Biology
Volume576
ISSN (Print)00652598

Fingerprint

Canavan Disease
Knockout Mice
Brain
Gene transfer
Stem cells
Viruses
Megalencephaly
Genes
Muscle Hypotonia
Cell- and Tissue-Based Therapy
Intellectual Disability
Stem Cells
aspartoacylase
N-acetylaspartate

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Matalon, R., Michals-Matalon, K., Surendran, S., & Tyring, S. K. (2006). Canavan disease: Studies on the knockout mouse. In Advances in Experimental Medicine and Biology (Vol. 576, pp. 77-93). (Advances in Experimental Medicine and Biology; Vol. 576). Springer New York. https://doi.org/10.1007/0-387-30172-0_6

Canavan disease : Studies on the knockout mouse. / Matalon, Reuben; Michals-Matalon, Kimberlee; Surendran, Sankar; Tyring, Stephen K.

Advances in Experimental Medicine and Biology. Vol. 576 Springer New York, 2006. p. 77-93 (Advances in Experimental Medicine and Biology; Vol. 576).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Matalon, R, Michals-Matalon, K, Surendran, S & Tyring, SK 2006, Canavan disease: Studies on the knockout mouse. in Advances in Experimental Medicine and Biology. vol. 576, Advances in Experimental Medicine and Biology, vol. 576, Springer New York, pp. 77-93. https://doi.org/10.1007/0-387-30172-0_6
Matalon R, Michals-Matalon K, Surendran S, Tyring SK. Canavan disease: Studies on the knockout mouse. In Advances in Experimental Medicine and Biology. Vol. 576. Springer New York. 2006. p. 77-93. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/0-387-30172-0_6
Matalon, Reuben ; Michals-Matalon, Kimberlee ; Surendran, Sankar ; Tyring, Stephen K. / Canavan disease : Studies on the knockout mouse. Advances in Experimental Medicine and Biology. Vol. 576 Springer New York, 2006. pp. 77-93 (Advances in Experimental Medicine and Biology).
@inproceedings{061d820532714f1bbd82b4212184ad58,
title = "Canavan disease: Studies on the knockout mouse",
abstract = "Canavan disease (CD) is an autosomal recessive disorder, characterized by spongy degeneration of the brain. Patients with CD have aspartoacylase (ASPA) deficiency, which results accumulation of N-acetylaspartic acid (NAA) in the brain and elevated excretion of urinary NAA. Clinically, patients with CD have macrocephaly, mental retardation and hypotonia. A knockout mouse for CD which was engineered, also has ASPA deficiency and elevated NAA. Molecular studies of the mouse brain showed abnormal expression of multiple genes in addition to ASPA deficiency. Adenoassociated virus mediated gene transfer and stem cell therapy in the knockout mouse are the latest attempts to alter pathophysiology in the CD mouse.",
author = "Reuben Matalon and Kimberlee Michals-Matalon and Sankar Surendran and Tyring, {Stephen K.}",
year = "2006",
doi = "10.1007/0-387-30172-0_6",
language = "English (US)",
isbn = "9780387301716",
volume = "576",
series = "Advances in Experimental Medicine and Biology",
publisher = "Springer New York",
pages = "77--93",
booktitle = "Advances in Experimental Medicine and Biology",

}

TY - GEN

T1 - Canavan disease

T2 - Studies on the knockout mouse

AU - Matalon, Reuben

AU - Michals-Matalon, Kimberlee

AU - Surendran, Sankar

AU - Tyring, Stephen K.

PY - 2006

Y1 - 2006

N2 - Canavan disease (CD) is an autosomal recessive disorder, characterized by spongy degeneration of the brain. Patients with CD have aspartoacylase (ASPA) deficiency, which results accumulation of N-acetylaspartic acid (NAA) in the brain and elevated excretion of urinary NAA. Clinically, patients with CD have macrocephaly, mental retardation and hypotonia. A knockout mouse for CD which was engineered, also has ASPA deficiency and elevated NAA. Molecular studies of the mouse brain showed abnormal expression of multiple genes in addition to ASPA deficiency. Adenoassociated virus mediated gene transfer and stem cell therapy in the knockout mouse are the latest attempts to alter pathophysiology in the CD mouse.

AB - Canavan disease (CD) is an autosomal recessive disorder, characterized by spongy degeneration of the brain. Patients with CD have aspartoacylase (ASPA) deficiency, which results accumulation of N-acetylaspartic acid (NAA) in the brain and elevated excretion of urinary NAA. Clinically, patients with CD have macrocephaly, mental retardation and hypotonia. A knockout mouse for CD which was engineered, also has ASPA deficiency and elevated NAA. Molecular studies of the mouse brain showed abnormal expression of multiple genes in addition to ASPA deficiency. Adenoassociated virus mediated gene transfer and stem cell therapy in the knockout mouse are the latest attempts to alter pathophysiology in the CD mouse.

UR - http://www.scopus.com/inward/record.url?scp=84934444189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84934444189&partnerID=8YFLogxK

U2 - 10.1007/0-387-30172-0_6

DO - 10.1007/0-387-30172-0_6

M3 - Conference contribution

SN - 9780387301716

VL - 576

T3 - Advances in Experimental Medicine and Biology

SP - 77

EP - 93

BT - Advances in Experimental Medicine and Biology

PB - Springer New York

ER -